HK1217690A1 - 作爲 型鈣通道阻滯劑的環戊基吡唑 - Google Patents

作爲 型鈣通道阻滯劑的環戊基吡唑

Info

Publication number
HK1217690A1
HK1217690A1 HK16105125.9A HK16105125A HK1217690A1 HK 1217690 A1 HK1217690 A1 HK 1217690A1 HK 16105125 A HK16105125 A HK 16105125A HK 1217690 A1 HK1217690 A1 HK 1217690A1
Authority
HK
Hong Kong
Prior art keywords
cyclopentylpyrazoles
calcium channel
channel blockers
type calcium
type
Prior art date
Application number
HK16105125.9A
Other languages
English (en)
Inventor
Michael Winters
Zhihua Sui
Christopher Flores
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49036654&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1217690(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1217690A1 publication Critical patent/HK1217690A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK16105125.9A 2012-08-16 2016-05-05 作爲 型鈣通道阻滯劑的環戊基吡唑 HK1217690A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261683775P 2012-08-16 2012-08-16
PCT/US2013/055267 WO2014028801A1 (en) 2012-08-16 2013-08-16 Cyclopentylpyrazoles as n-type calcium channel blockers

Publications (1)

Publication Number Publication Date
HK1217690A1 true HK1217690A1 (zh) 2017-01-20

Family

ID=49036654

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16105125.9A HK1217690A1 (zh) 2012-08-16 2016-05-05 作爲 型鈣通道阻滯劑的環戊基吡唑

Country Status (21)

Country Link
US (1) US8853418B2 (zh)
EP (1) EP2885279A1 (zh)
JP (1) JP6262231B2 (zh)
KR (1) KR20150042270A (zh)
CN (1) CN105189464B (zh)
AU (1) AU2013302469B2 (zh)
BR (1) BR112015003328A2 (zh)
CA (1) CA2882042A1 (zh)
CL (1) CL2015000357A1 (zh)
CR (1) CR20150068A (zh)
EA (1) EA201590382A1 (zh)
EC (1) ECSP15009830A (zh)
HK (1) HK1217690A1 (zh)
IL (1) IL237189A0 (zh)
IN (1) IN2015DN01237A (zh)
MX (1) MX2015002037A (zh)
PE (1) PE20151137A1 (zh)
PH (1) PH12015500314A1 (zh)
SG (1) SG11201501140RA (zh)
WO (1) WO2014028801A1 (zh)
ZA (1) ZA201501746B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9974775B2 (en) 2013-08-16 2018-05-22 Janssen Pharmaceutica Nv Substituted imidazoles as N-type calcium channel blockers

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201590381A1 (ru) 2012-08-16 2015-07-30 Янссен Фармацевтика Нв Замещенные пиразолы, используемые в качестве блокаторов кальциевых каналов n-типа
EP2957559A1 (en) * 2014-06-18 2015-12-23 L'Universite de Strasbourg Iminosydnone derivatives for conjugation and release of compounds of interest

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1287174B1 (it) * 1996-11-15 1998-08-04 Angelini Ricerche Spa Diaril-ciclometilenpirazoli farmacologicamente attivi,procedimento per prepararli e composizioni farmaceutiche che li contengono
JP2001220390A (ja) * 2000-02-09 2001-08-14 Yamanouchi Pharmaceut Co Ltd 縮合ピラゾール誘導体
CN1938281A (zh) * 2004-03-08 2007-03-28 惠氏公司 离子通道调节剂
AU2005221138A1 (en) * 2004-03-08 2005-09-22 Wyeth Ion channel modulators
CA2628260A1 (en) * 2005-11-09 2007-05-18 Abbott Laboratories 2-phenyl-2h-pyraz0le derivatives as p2x7 receptor antagonists and uses thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9974775B2 (en) 2013-08-16 2018-05-22 Janssen Pharmaceutica Nv Substituted imidazoles as N-type calcium channel blockers

Also Published As

Publication number Publication date
ECSP15009830A (es) 2015-12-31
CL2015000357A1 (es) 2015-06-12
WO2014028801A1 (en) 2014-02-20
US8853418B2 (en) 2014-10-07
PH12015500314A1 (en) 2015-03-30
SG11201501140RA (en) 2015-04-29
JP6262231B2 (ja) 2018-01-17
CN105189464A (zh) 2015-12-23
CR20150068A (es) 2015-04-30
US20140051660A1 (en) 2014-02-20
CN105189464B (zh) 2017-12-12
MX2015002037A (es) 2016-01-22
ZA201501746B (en) 2017-08-30
EA201590382A1 (ru) 2015-08-31
IL237189A0 (en) 2015-04-30
EP2885279A1 (en) 2015-06-24
AU2013302469B2 (en) 2017-08-24
AU2013302469A1 (en) 2015-02-26
JP2015524851A (ja) 2015-08-27
PE20151137A1 (es) 2015-08-07
KR20150042270A (ko) 2015-04-20
BR112015003328A2 (pt) 2017-07-04
CA2882042A1 (en) 2014-02-20
IN2015DN01237A (zh) 2015-06-26

Similar Documents

Publication Publication Date Title
HK1217946A1 (zh) 司普力西歐他汀類似物
HK1204513A1 (zh) 質量驅動型流
HK1201200A1 (zh) 取代的吡咯烷- -甲酰胺
HK1200830A1 (zh) 取代的吡咯烷- -甲酰胺
IL237190A0 (en) Pyrazoles are converted as n-type calcium channel blockers
HK1204797A1 (zh) 新穎的抗- 抗體
HK1214860A1 (zh) 作為 型鈣通道阻滯劑的取代的吡唑
GB201222970D0 (en) Synchronization
HK1206724A1 (zh) 取代的苯並噻吩並嘧啶
IL233059A0 (en) Synthetic Wakanjin
IL237192A0 (en) Pyrrolopyrazoles as n-type calcium channel blockers
EP2934541A4 (en) NORIBOGAINE SUBSTITUTE
HK1206022A1 (zh) 取代的咪唑並噠嗪
GB201903206D0 (en) n
HK1217690A1 (zh) 作爲 型鈣通道阻滯劑的環戊基吡唑
GB2518990B (en) Controls
GB201210472D0 (en) Obtaining control words
GB201201720D0 (en) Novel combinations
PL2904155T3 (pl) Rynna odwadniająca
PL2617907T3 (pl) Rynna szczelinowa
GB201216524D0 (en) Project P
GB201210379D0 (en) SycoSocial app
GB201208427D0 (en) Findmii app
GB201208428D0 (en) Missumuch app
GB201208429D0 (en) Rememberme app